Trials / Conditions / Acute Pyelonephritis

Acute Pyelonephritis

28 registered clinical trials studyying Acute Pyelonephritis — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Recruiting	A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Meropenem-Vaborbactam in Children With C NCT06672978	Rempex (a wholly owned subsidiary of Melinta Therapeutics, LLC)	Phase 2
Unknown	Study of Cefepime-tazobactam (FEP-TAZ) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis ( NCT03630081	Wockhardt	Phase 3
Completed	A Study of Oral Tebipenem Pivoxil Hydrobromide (TBP-PI-HBr) Compared to Intravenous Imipenem-cilastatin in Par NCT06059846	Spero Therapeutics	Phase 3
Completed	NGS-Based Assay of Blood Samples of Sepsis Patients for Rapid Bacterial Identification NCT06141395	Hellenic Institute for the Study of Sepsis	—
Completed	P3 Study to Assess Efficacy and Safety of Cefepime/Nacubactam and Aztreonam/Nacubactam Versus Best Available T NCT05905055	Meiji Seika Pharma Co., Ltd.	Phase 3
Completed	Efficacy and Safety of Cefepime/Nacubactam or Aztreonam/Nacubactam Compared to Imipenem/Cilastatin in Subjects NCT05887908	Meiji Seika Pharma Co., Ltd.	Phase 3
Completed	Study of Cefepime-zidebactam (FEP-ZID) in Complicated Urinary Tract Infection (cUTI) or Acute Pyelonephritis ( NCT04979806	Wockhardt	Phase 3
Unknown	Meropenem-FL058 Phase 2 Study in the Treatment of Complicated Urinary Tract Infections NCT05060419	Qilu Pharmaceutical Co., Ltd.	Phase 2
Completed	Efficacy and Safety of CAZ-AVI in the Treatment of Infections Due to Carbapenem-resistant G- Pathogens in Chin NCT04882085	Pfizer	Phase 4
Unknown	Efficacy of Corticosteroids in Reducing Renal Scarring in Acute Pyelonephritis in Children NCT04654507	Hamad Medical Corporation	Phase 3
Completed	Accuracy of Infection Biomarkers in the Investigation of Patients With Suspected Acute Pyelonephritis NCT04686318	University of Southern Denmark	—
Completed	Clinical Characteristics of Acutely Hospitalized Adults With Acute Pyelonephritis NCT04667195	University of Southern Denmark	—
Unknown	Bacterial Metallophores in the Diagnosis of Acute Pyelonephritis NCT05674032	Thomayer University Hospital	—
Completed	Safety and Efficacy Study of Cefepime/VNRX-5133 in Patients With Complicated Urinary Tract Infections NCT03840148	Venatorx Pharmaceuticals, Inc.	Phase 3
Completed	Study to Assess the Efficacy, Safety and Pharmacokinetics of Orally Administered Tebipenem Pivoxil Hydrobromid NCT03788967	Spero Therapeutics	Phase 3
Completed	IV or IV/PO Omadacycline vs. IV/PO Levofloxacin for the Treatment of Acute Pyelonephritis NCT03757234	Paratek Pharmaceuticals Inc	Phase 2
Completed	Evaluation of Safety and Efficacy of Intravenous Sulbactam-ETX2514 in the Treatment of Hospitalized Adults Wit NCT03445195	Entasis Therapeutics	Phase 2
Completed	Safety and Efficacy of ZTI-01 (IV Fosfomycin) vs Piperacillin/Tazobactam for Treatment cUTI/AP Infections NCT02753946	Nabriva Therapeutics AG	Phase 2 / Phase 3
Completed	A Study of Plazomicin Compared With Meropenem for the Treatment of Complicated Urinary Tract Infection (cUTI) NCT02486627	Achaogen, Inc.	Phase 3
Completed	Efficacy/Safety of Meropenem-Vaborbactam Compared to Piperacillin-Tazobactam in Adults With cUTI and AP NCT02166476	Melinta Therapeutics, Inc.	Phase 3
Completed	Efficacy, Safety, Tolerability of Vabomere Compared to Best Available Therapy in Treating Serious Infections i NCT02168946	Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)	Phase 3
Completed	Study of Cases of Serious Infections Due to Carbapenem-Resistant Enterobacteriaceae NCT02420366	Rempex (a wholly owned subsidiary of Melinta Therapeutics, Inc.)	—
Completed	CSE-1034 (Ceftriaxone+ Sulbactam+ EDTA) Compared to Meropenem in Complicated Urinary Tract Infections (cUTIs) NCT03477422	Venus Remedies Limited	Phase 3
Completed	Dexamethasone Administration in 1st Episode of Febrile Urinary Tract Infection NCT02034851	Institut Investigacio Sanitaria Pere Virgili	—
Completed	Finafloxacin for the Treatment of cUTI and/or Acute Pyelonephritis NCT01928433	MerLion Pharmaceuticals GmbH	Phase 2
Unknown	Sitafloxacin and Ertapenem Treatment for Acute Pyelonephritis Caused by Escherichia Coli NCT02537847	Mahidol University	Phase 2
Completed	A Study of Plazomicin Compared With Levofloxacin for the Treatment of Complicated Urinary Tract Infection (cUT NCT01096849	Achaogen, Inc.	Phase 2
No Longer Available	Expanded Access Use of Sulopenem Etzadroxil/Probenecid for Complicated Urinary Tract Infection NCT04682834	Iterum Therapeutics, International Limited	—